ArticleInvestigational new drugs2013

Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent.

Matthew Burge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.